Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Current Oncology Reports|October 17, 2014
Gestational trophoblastic tumours: an update for 2014Fieke E M Froeling, Michael J SecklJournal of Biotechnology|January 20, 2010
Pancreatic cancer organotypic culturesFieke E M Froeling, John F Marshall, Hemant M KocherCancers|November 11, 2022
Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic CancerAdam S Bryce, Stephan B Dreyer, Fieke E M Froeling, et al.Journal of Clinical Medicine|January 7, 2021
Molecular Subtyping and Precision Medicine for Pancreatic CancerFieke E M Froeling, Raffaella Casolino, Antonio Pea, et al.Analytical Chemistry|March 23, 2023
Internally Controlled and Dynamic Optical Measures of Functional Tumor BiologyTaemoon Chung, Libia Garcia, Manojit M Swamynathan, et al.The American Journal of Pathology|July 18, 2009
Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cellsFieke E M Froeling, Tariq A Mirza, Roger M Feakins, et al.BMC Cancer|January 20, 2025
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2Hemant M Kocher, , , et al.Gastroenterology|June 28, 2011
Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progressionFieke E M Froeling, Christine Feig, Claude Chelala, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 25, 2013
Ezrin expression is an independent prognostic factor in gastro-intestinal cancersPrabhu Arumugam, Stefano Partelli, Stacey J Coleman, et al.British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.Pageof 3